Management of patients with gastrointestinal stromal tumors: Experience from an Italian hospital

Tumori

Volumn 91, Issue 6, 2005, Pages 467-471

  Cavaliere, Davide ^a   Griseri, Guido ^a   Venturino, Ezio ^a   Schirru, Angelo ^a   Cosce, Umberto ^a   Caristo, Ilario ^a   Caliendo, Luigi ^a   Pastorino, Alessandra ^a   Cavaliere, Paolo ^a  

^a San Paolo Hospital   (Italy)

Author keywords

CD117; Gastrointestinal neoplasms; Gastrointestinal stromal tumors

Indexed keywords

IMATINIB; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITALY; MALE; MESENCHYME; MITOSIS; MORBIDITY; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; STOMACH; STROMA CELL; TUMOR VOLUME;

EID: 32844465625     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100604     Document Type: Article

References (21)

1. Fletcher C, Berman JJ, Corless C: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol, 33: 459-465, 2002.
2. Graadt von Roggen JF, van Vekthuysen ML, Hogendoorn PC: The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol, 54: 96-102, 2001.
3. Kim CJ, Day S, Yeh KA: Gastrointestinal stromal tumors. Analysis of clinical and pathologic factors. Am Surg, 67: 135-137, 2001.
4. Corless CL, Fletcher JA, Heinrich MC: Biology of gastrointestinal stromal tumors, J Clin Oncol, 22: 3813-3825, 2004.
5. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC: Kit mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol, 160: 1567-1572, 2002.
6. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M: Embryonic form of smooth muscle myosin heavy chain (Smemb/MHC-B) in gastrointestinal stromal tumors and intestitial cells of Cajal. Am J Pathol, 154: 23-28, 1999.
7. Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J, Lendahl U, Nakasho K, Sugihara A, Iwasaki T, Mano M, Yamada N, Yamashita K, Toyosaka A, Terada N: Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol, 158: 817-823, 2001.
8. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitials cells of Cajal. Am J Pathol, 152: 1259-1269, 1998.
9. Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A: W/kit gene required for intestinal cells of Cajal and for intestinal pacemaker activity. Nature, 373: 347-349, 1995.
10. Hirota S, Isozaki K, Moryama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutation of c-kit in human gastrointestinal stromal tumors. Science, 279: 577-580, 1998.
11. Van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group: Safety and efficacy of imatinib (ST571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet, 358: 1421-1423, 2001.
12. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 347: 472-480, 2002.
13. Verweij J, van Oosterom A, Blay Jy, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PC, di Paola ED, Brown M, Nielsen OS: Imatinib mesylate (STI-571, Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: results from an EORTC Soft Tissue and Sarcoma group phase II study. Eur J Cancer, 39: 2006-2011, 2003.
14. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA: PDGFR activating mutations in gastrointestinal stromal tumors. Science, 299: 708-710, 2003.
15. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival. Ann Surg, 231: 51-58, 2000.
16. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ: The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg, 136: 383-389, 2001.
17. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM: Gastrointestinal autonomic nerve tumors. A clinical-pathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol, 17: 887-897, 1993.
18. O'Leary T, Berman JJ. Gastrointestinal stromal tumors: Answers and questions. Human Pathol, 33: 456-458, 2002.
19. Miettinen M, El-rifai W, Sobin LH: Evaluation of malignancy and prognosis of gastrointestinal tumors: a review. Human Pathol, 33: 478-483, 2001.
20. Miettinen M, Lasota J: Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 438: 1-12, 2001.
21. Joensuu H, Kindblom LG: Gastrointestinal stromal tumors: a review. Acta Orthop Scand Suppl, 75: 62-71, 2004.